I fully agree Terryz. Im sure they must already be in some discussion with a Big Pharma or two on a deal that would encompass the entire vaccine program that rolls out from the Prof Frazer breakthrough in DNA vaccinnes.
Their confidence in the HSV2 vaccinne appears very high and thus I think they will await at least startling preliminary results from the phase 2 trial before finalising any partner deal ....the delay until then thus placing admedus in a stronger bargaining position.
Fox
Nice finish, page-49
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.90 |
Change
0.200(1.57%) |
Mkt cap ! $272.6M | |||
| Open | High | Low | Value | Volume |
| $12.62 | $12.99 | $12.61 | $210.9K | 16.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1099 | $12.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.98 | 246 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |